Article Text

PDF

Cerebral Erdheim-Chester disease: report of two cases with progressive cerebellar syndrome with dentate abnormalities on magnetic resonance imaging
  1. Eric Pautasa,
  2. Patrick Chérina,
  3. Sophie Pelletiera,
  4. Marie Vidailhetb,
  5. Serge Hersona
  1. aDepartment of Internal Medecine, bDepartment of Neurology, Hôpital de la Pitié-Salpétrière, Paris, France
  1. Dr Chérin, Service de Médecine Interne, Hôpital de la Salpétrière, 47 bd de l’Hôpital, 75856 Paris Cedex, France. Fax 0033 1 42 16 10 58.

Abstract

Two patients with Erdheim-Chester disease with progressive cerebellar dysfunction and pyramidal signs are reported on. Cerebral MRI showed bilateral increased signal intensity in peridentatal regions on T2 weighted sequences. Both patients had kidney and bone involvement, established on bone biopsy for one. One patient improved with steroid therapy. This contrasts with previous reports, which describe rare neurological manifestations and the failure of different therapeutic approaches.

  • Erdheim-Chester disease
  • cerebellar syndrome
  • pyramidal signs
  • magnetic resonance imaging

Statistics from Altmetric.com

Erdheim-Chester disease is a rare, non-Langerhans form of systemic histiocytosis of unknown aetiology.1 It is associated with tissue infiltration by foamy histiocytes. Intracranial manifestations are rare and the usual localisations are the retro-orbital space and hypothalamic involvement with neurogenic diabetes insipidus. Neurological manifestations are less frequent.2 Only a few patients with cerebellar dysfunction have been described.3 4 We report on two patients with Erdheim-Chester disease with slowly progressive cerebellar dysfunction, associated with pyramidal symptoms. The most frequent systemic manifestations are bone lesions. They are characterised by bilateral, symmetric sclerosis of the metaphyseal regions of the long bones. The clinical picture ranges from focal bone lesions to systemic disease with life threatening visceral involvement.1 2

Case reports

PATIENT 1

A 31 year old man was diagnosed in 1986 as having histiocytosis X because of pulmonary fibrosis and radiological maxillary lytic lesions. Diagnosis was established by pulmonary biopsies. No treatment was given. Three years later, he developed bone pain with radiological sclerotic lesions in the proximal parts of the tibias and distal parts of the femurs. It was considered to be specific bone involvement in histiocytosis X. Chemotherapy (six regimens of vinblastin and corticosteroids, then two regimens of methotrexate) was administered. In 1991 neurological examination showed cerebellar ataxia and bilateral Babinski’s signs. In 1994, after three years of progressive neurological dysfunction, diagnosis of Erdheim-Chester disease was made by analysis of biopsies of the femur bones, showing infiltration with foamy histiocytes lacking Birbeck granules and S-100 protein, and with few lymphocytes. From 1990 to 1994, blood test results showed chronic inflammation: C reactive protein 92 to 140 mg/l (normal<4 mg/l), erythrocyte sedimentation rate 50 to 100 mm, and plasmatic fibrin 7 to 13 g/l. Serum triglyceride concentrations were normal. Abdominal echography and CT showed “fat kidneys” with perirenal infiltration. There was no abnormality on brain CT but cerebral MRI showed abnormal increased signal intensity on T2 weighted sequences in the sphenoidal region and in both dentate nuclei.

In 1996, bone lesions and radiological findings were unchanged. Cerebellar dysfunction was slowly progressive. The patient was treated with corticosteroids (10 mg prednisone/day) for 2 years without success.

PATIENT 2

A 62 year old woman without medical history was admitted in December 1995 for biological inflammatory syndrome and ataxia. Neurological examination showed cerebellar ataxia and dysmetria of four limbs, tetrapyramidal syndrome with brisk deep tendon reflexes of four limbs, and bilateral Babinski’s signs. There was a right central scotoma secondary to inflammatory optic neuritis. General examination showed bilateral periorbital xanthoma but no tendon swelling.

Laboratory tests found chronic inflammation with C reactive protein of 50 mg/l (normal<4 mg/l), erythrocyte sedimentation rate of 99 mm, polyclonal hypergammaglobulinaemia, and hypertriglyceridaemia (4 mmol/l; normal<1.65 mmol/l). The serum vitamin E concentration was within normal limits. Thyroid, renal, hepatic, and phosphocalcic functions were normal. Abdominal echography disclosed enlarged renal calices. Brain CT was normal and CSF was normal. The suspected diagnosis was olivopontocerebellar atrophy associated with inflammatory disease. Corticosteroid therapy was initiated in December 1995 (1 mg/kg/day prednisone). Within six months, neurological examination showed a marked regression of cerebellar ataxia and dysmetria but unchanged pyramidal symptoms. Cerebral MRI showed an abnormally increased signal intensity on T2 weighted sequences in peridentate regions (fig 1) and on the right optic nerve. Scintigraphy with gallium showed an increased uptake in the periorbital, maxillary, and right humeral areas. Skeletal scintigraphy showed symmetrically increased uptake in the distal parts of the femurs, the proximal and distal parts of the tibias, and the face. Bone radiography showed the typical lesions of Erdheim-Chester disease with patchy sclerosis and osteolysis in the distal parts of the femurs and tibias (fig 2). Abdominal CT showed infiltration of kidneys and perirenal tissues without evidence of retroperitoneal fibrosis or obstructions in the ureters.

Figure 1

Brain MRI showing bilateral hypersignal of peridentatal regions on T2 weighted sequences, without cerebellar atrophy.

Figure 2

Femur and tibia radiography showing sclerosis of the metaphyseal regions with areas of osteolysis.

 The patient died a few weeks later with an unexplained metabolic acidosis. The patient was diagnosed as having Erdheim-Chester disease with multisystemic involvement (bone, kidney, CNS).

Discussion

We report here on two patients with Erdheim-Chester disease with neurological involvement. Our patients had similar neurological presentations with cerebellar dysfunction associated with pyramidal signs. Cerebral MRI showed bilateral increased signal intensity in the dentate region on T2 weighted sequences. Both patients had kidney and bone involvement, patient 1 with pathologically established diagnosis of Erdheim-Chester disease on bone biopsy. The clinical and radiological findings for patient 2 are sufficiently characteristic to be diagnostic of Erdheim-Chester disease.2

A patient with cerebellar dysfunction has recently been reported by Fukazawa et al 4; a 59 year old woman developed slowly progressive cerebellar dysfunction (with a follow up of 11 years) associated with bilateral Babinski’s signs. T2 weighted cerebral MRI showed hyperintensity in both dentate nuclei. This type of neurological involvement of Erdheim-Chester disease has been reported a few times before.3

 Other neurological manifestations are rare. Three patients had motor deficits, hemiparesis, or paraplegia5 6; two patients were confused7 8; four patients had ataxia or impaired coordination, but the authors did not state whether they had cerebellar or proprioceptive dysfunction.8-10

Neuroradiological findings indicate brain infiltration in four patients. Brain MRI findings include isosignal on T1 weighted sequences with enhancement after gadolinium, and increased signal intensity on T2 weighted sequences.6 8 The other localisations for intracranial accumulation of histiocytes were the retro-orbital space with exolphtalmos (16 patients) or diplopia (four patients), and the hypophyso-hypothalamic area with diabetes insipidus (17 patients).2

The most frequent systemic histiocytosis is histiocytosis X, now called Langerhans cell histiocytosis, which includes three entities: Hand-Shüller-Christian disease, Letterer-Siwe disease, and eosinophilic granuloma. Erdheim-Chester disease differs from Langerhans cell histiocytosis by the immunohistological and microscopical characteristics of the histiocytes. Erdheim-Chester disease is a rare multisystemic xanthogranulomatous infiltrative disease of unknown aetiology, due to infiltration of different organs and bones by foamy histiocytes.1 The extraskeletal involvement is various: enlarged kidneys by renal infiltration, hydronephrosis, retroperitoneal fibrosis, pelvic infiltration, pulmonary interstitial infiltration or fibrosis, pleural thickening or effusion, pericardial effusion, intracranial infiltration.2

A total of 59 patients have been reported. In a review of the literature, Veyssier- Belot et al showed that only 11 of these patients fulfilled all the diagnostic criteria for Erdheim-Chester disease.2 The specific signs are radiological and histological features in bone. The characteristic radiographical finding is bilateral, symmetric osteosclerosis of the long bones. Osteolytic lesions are described in Langerhans cell histiocytosis but not in the long bones. Full histological criteria are xanthomatous or xanthogranulomatous infiltration by fibrosis with lack of S-100 protein and of intracytoplasmic Birbeck granules, both described in Langherans cell histiocytosis.1 2

The pathogenesis of neurological manifestations in Erdheim-Chester disease remains an unknown and intriguing issue particularly in the light of the improvement of cerebellar symptoms after corticosteroid therapy for 2 months, which has not been previously reported. Our findings broaden the clinical range of known neurological manifestations in Erdheim-Chester disease and suggest that hyperintensity of dentate nuclei on MRI in association with pseudoprogressive olivopontocerebellar degeneration could suggest the diagnosis of Erdheim-Chester disease. Skeletal survey of the long bones and ophtalmological examination are indicated for such patients to confirm the diagnosis.

References

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.